Madrigal Pharmaceuticals (0JXI.LSE) Q3 2024 Earnings

Aug 7Confirmed
Aug 2021
Q4 2023
Q2 2024
Q3 2024
-7.54
-6.26
-4.99
-3.72

Details

Expected EPS
-7.536514
Actual EPS
-7.1
Surprise EPS
0.44
Surprise Percent
+5.79%

Description

⁨Madrigal Pharmaceuticals⁩ (⁦0JXI.LSE⁩) has reported earnings of ⁦-7.1⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts